These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33275045)

  • 1. Methods for the discovery of small molecules to monitor and perturb the activity of the human proteasome.
    Maresh ME; Salazar-Chaparro AF; Trader DJ
    Future Med Chem; 2021 Jan; 13(2):99-116. PubMed ID: 33275045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome Activation as a New Therapeutic Approach To Target Proteotoxic Disorders.
    Njomen E; Tepe JJ
    J Med Chem; 2019 Jul; 62(14):6469-6481. PubMed ID: 30839208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a suite of assays that support the discovery of proteasome stimulators.
    Trader DJ; Simanski S; Dickson P; Kodadek T
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):892-899. PubMed ID: 28065760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Proteasome Enhancement by Small Molecules.
    George DE; Tepe JJ
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of proteasome assembly and activity in health and disease.
    Rousseau A; Bertolotti A
    Nat Rev Mol Cell Biol; 2018 Nov; 19(11):697-712. PubMed ID: 30065390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional evidence for citicoline binding and modulation of 20S proteasome activity: Novel insights into its pro-proteostatic effect.
    Sbardella D; Coletta A; Tundo GR; Ahmed IMM; Bellia F; Oddone F; Manni G; Coletta M
    Biochem Pharmacol; 2020 Jul; 177():113977. PubMed ID: 32298691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to Discover and Evaluate Proteasome Small Molecule Stimulators.
    Coleman RA; Trader DJ
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31242677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Synuclein protofibrils inhibit 26 S proteasome-mediated protein degradation: understanding the cytotoxicity of protein protofibrils in neurodegenerative disease pathogenesis.
    Zhang NY; Tang Z; Liu CW
    J Biol Chem; 2008 Jul; 283(29):20288-98. PubMed ID: 18502751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PA28γ: New Insights on an Ancient Proteasome Activator.
    Cascio P
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33562807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and Development of Cyclic Peptide Proteasome Stimulators.
    Nelson S; Harris TJ; Muli CS; Maresh ME; Baker B; Smith C; Neumann C; Trader DJ; Parkinson EI
    Chembiochem; 2024 Feb; 25(3):e202300671. PubMed ID: 38055197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome Based Molecular Strategies Against Improper Cellular Proliferation.
    Dubey AR; Kinger S; Jagtap YA; Patwa SM; Kumar P; Singh S; Kumar A; Kumar A; Mishra A
    Cell Physiol Biochem; 2021 Oct; 55(S2):120-143. PubMed ID: 34655466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A High-Content Screening Assay for the Discovery of Novel Proteasome Inhibitors from Formosan Soft Corals.
    Ling XH; Wang SK; Huang YH; Huang MJ; Duh CY
    Mar Drugs; 2018 Oct; 16(10):. PubMed ID: 30347865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes.
    Villoutreix BO; Khatib AM; Cheng Y; Miteva MA; Maréchal X; Vidal J; Reboud-Ravaux M
    Oncotarget; 2017 Feb; 8(6):10437-10449. PubMed ID: 28060729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the role of proteasome homeostasis in Parkinson's disease: beyond protein breakdown.
    Bi M; Du X; Jiao Q; Chen X; Jiang H
    Cell Death Dis; 2021 Feb; 12(2):154. PubMed ID: 33542205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Resolution Snapshots of Proteasome Inhibitors in Action Revise Inhibition Paradigms and Inspire Next-Generation Inhibitor Design.
    Carmony K; Lee W; Kim KB
    Chembiochem; 2016 Nov; 17(22):2115-2117. PubMed ID: 27605113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview.
    Guedes RA; Serra P; Salvador JA; Guedes RC
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality control of mislocalized and orphan proteins.
    Kong KE; Coelho JPL; Feige MJ; Khmelinskii A
    Exp Cell Res; 2021 Jun; 403(2):112617. PubMed ID: 33930402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primed for Interactions: Investigating the Primed Substrate Channel of the Proteasome for Improved Molecular Engagement.
    Loy CA; Trader DJ
    Molecules; 2024 Jul; 29(14):. PubMed ID: 39064934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases.
    VerPlank JJS; Tyrkalska SD; Fleming A; Rubinsztein DC; Goldberg AL
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14220-14230. PubMed ID: 32513741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers.
    Thibaudeau TA; Anderson RT; Smith DM
    Nat Commun; 2018 Mar; 9(1):1097. PubMed ID: 29545515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.